Anemia in chronic diffuse liver diseases

Relevance. In recent decades, in many countries of the world, there has been a trend towards an increase in the number of patients with chronic diffuse liver diseases (CDLD), especially among people of young working age. CDPD is characterized by a severe course, poor prognosis, and is one of the main causes of disability in patients in developed countries [1,2]. According to WHO, cirrhosis of the liver (LC) ranks eighth among the causes of death. Therefore, the study of the features of epidemiology, clinic, diagnosis, treatment of these diseases is one of the urgent problems of modern hepatology.